Drug
Hexavalent Vaccine
Hexavalent Vaccine: highest development phase Phase 1/2, developed by Serum Institute of India Pvt. Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Serum Institute of India Pvt. Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Hexavalent (DTwP-HepB-rPV-Hib) Vaccine NCT07855172 | Phase 1/2 | Diptheria Immunization |
Latest
No recent events.
Follow Hexavalent Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.